Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 12  •  04:00PM ET
78.29
Dollar change
-1.39
Percentage change
-1.74
%
Index- P/E36.33 EPS (ttm)2.15 Insider Own1.08% Shs Outstand494.40M Perf Week-2.35%
Market Cap38.72B Forward P/E22.32 EPS next Y3.51 Insider Trans0.00% Shs Float489.23M Perf Month-9.47%
Enterprise Value42.59B PEG3.80 EPS next Q0.76 Inst Own57.23% Short Float1.02% Perf Quarter-12.15%
Income1.07B P/S3.86 EPS this Y1.60% Inst Trans1.33% Short Ratio2.62 Perf Half Y-9.81%
Sales10.03B P/B1.75 EPS next Y13.18% ROA3.51% Short Interest5.00M Perf YTD-7.77%
Book/sh44.73 P/C27.50 EPS next 5Y9.55% ROE4.98% 52W High101.10 -22.56% Perf Year-20.21%
Cash/sh2.85 P/FCF23.93 EPS past 3/5Y38.96% - ROIC3.94% 52W Low77.44 1.10% Perf 3Y15.39%
Dividend Est.0.35 (0.44%) EV/EBITDA15.58 Sales past 3/5Y6.13% 5.71% Gross Margin55.13% Volatility1.82% 1.77% Perf 5Y41.04%
Dividend TTM0.66 (0.84%) EV/Sales4.25 EPS Y/Y TTM-2.88% Oper. Margin14.80% ATR (14)1.76 Perf 10Y-
Dividend Ex-DateMay 14, 2025 Quick Ratio1.61 Sales Y/Y TTM4.04% Profit Margin10.70% RSI (14)39.19 Recom1.69
Dividend Gr. 3/5Y13.30% - Current Ratio2.60 EPS Q/Q-21.22% SMA20-3.45% Beta1.00 Target Price97.31
Payout15.44% Debt/Eq0.24 Sales Q/Q4.01% SMA50-7.93% Rel Volume0.68 Prev Close79.68
Employees25599 LT Debt/Eq0.23 EarningsAug 19 AMC SMA200-11.10% Avg Volume1.91M Price78.29
IPOApr 09, 2019 Option/ShortYes / Yes EPS/Sales Surpr.6.22% -1.76% Trades Volume1,309,265 Change-1.74%
Date Action Analyst Rating Change Price Target Change
Aug-21-25Downgrade JP Morgan Overweight → Neutral
May-20-25Downgrade Deutsche Bank Buy → Hold
May-14-25Reiterated BTIG Research Buy $102 → $99
Mar-28-25Reiterated Needham Buy $107 → $110
Mar-25-25Upgrade BofA Securities Neutral → Buy
Jan-24-25Reiterated Needham Buy $108 → $106
Jan-10-25Upgrade Redburn Atlantic Neutral → Buy
Dec-17-24Reiterated Needham Buy $103 → $108
Nov-12-24Reiterated Needham Buy
Oct-10-24Upgrade Redburn Atlantic Sell → Neutral
Sep-11-25 12:19PM
Sep-08-25 01:01AM
Sep-02-25 10:40AM
10:10AM
Aug-26-25 08:00AM
10:44AM Loading…
Aug-21-25 10:44AM
10:12AM
09:36AM
03:06AM
Aug-20-25 03:49PM
01:08PM
09:47AM
09:41AM
05:56AM
05:03AM
03:46AM Loading…
03:46AM
Aug-19-25 06:30PM
04:30PM
12:08AM
Aug-18-25 11:00PM
Aug-14-25 09:15AM
Aug-06-25 09:36AM
Aug-05-25 09:27AM
01:43AM
01:01AM
Aug-02-25 07:48AM
Jul-23-25 07:50AM
Jul-22-25 08:45AM
Jul-09-25 08:29AM
08:18AM
09:01AM Loading…
Jul-08-25 09:01AM
Jul-07-25 08:00AM
Jul-06-25 03:35AM
Jul-03-25 04:49PM
Jul-02-25 08:17AM
Jun-26-25 09:03AM
Jun-20-25 09:02AM
Jun-02-25 08:43AM
May-30-25 07:50AM
May-29-25 09:31AM
May-28-25 11:58PM
04:40PM
May-15-25 09:42AM
May-14-25 07:22PM
08:49AM
May-13-25 06:00PM
04:30PM
May-12-25 07:00PM
04:18PM
May-11-25 05:00AM
May-08-25 09:15AM
May-06-25 04:30PM
May-01-25 03:54PM
10:14AM
Apr-30-25 07:27PM
Apr-28-25 06:34AM
Apr-27-25 11:02PM
Apr-25-25 08:00AM
Apr-16-25 11:09AM
Apr-13-25 04:19PM
Apr-11-25 10:10AM
Apr-10-25 01:59PM
Apr-09-25 06:33AM
Apr-08-25 10:45AM
Apr-07-25 06:15AM
Apr-04-25 01:00AM
Apr-03-25 06:51PM
07:56AM
Apr-02-25 08:00AM
Apr-01-25 10:49AM
01:03AM
Mar-31-25 09:10AM
Mar-28-25 11:30AM
07:28AM
Mar-27-25 04:34PM
Mar-26-25 11:10PM
04:30PM
Mar-25-25 03:10PM
09:00AM
08:44AM
08:35AM
01:00AM
Mar-24-25 08:00AM
Mar-13-25 09:02AM
Mar-04-25 03:04PM
Feb-27-25 09:02AM
Feb-26-25 03:20PM
Feb-25-25 04:30PM
Feb-24-25 08:02AM
Feb-19-25 08:02AM
Dec-31-24 04:30PM
Nov-13-24 01:25PM
Nov-12-24 12:09PM
Nov-07-24 01:00AM
Oct-27-24 09:00PM
Oct-15-24 09:03AM
Sep-05-24 07:54PM
Sep-04-24 03:29PM
Aug-27-24 06:42PM
Aug-21-24 04:22PM
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Duplan SergioOfficerMar 03 '25Proposed Sale93.2012,6001,174,320Mar 03 01:04 PM
STONESIFER TIMOTHY C.OfficerFeb 28 '25Proposed Sale92.0920,0001,841,800Feb 28 02:49 PM
Attias LaurentOfficerFeb 27 '25Proposed Sale91.889,000826,920Feb 27 10:56 AM